Structured evidence table for Amla Blood Lipids Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Amla Blood Lipids Meta-Analysis | 1 2 3 4 Polycystic ovary syndrome (PCOS) is among the most frequent endocrine disorders in women of reproductive age and is strongly associated with multiple cardiometabolic disturbances. | 4 | Muacevic Alexander (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review |
| Amla Blood Lipids Meta-Analysis | While these approaches can reduce symptoms, they mostly do not address the underlying endocrine or metabolic disturbances and may be associated with adverse effects, including gastrointestinal discomfort, weight gain, and fatigue [,]. | 4 | Muacevic Alexander (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review |
| Amla Blood Lipids Meta-Analysis | Increasing evidence also points to the benefits of curcumin, a polyphenolic compound from turmeric, which down-regulates inflammatory mediators and oxidative stress, thereby improving insulin action []. | 4 | Muacevic Alexander (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review |
| Amla Blood Lipids Meta-Analysis | Globally, the condition affects roughly 4-20% of women, underscoring its significance as a public-health concern [,]. | 4 | Muacevic Alexander (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review |
| Amla Blood Lipids Meta-Analysis | Background: Hyperlipidemia is associated with a higher rate of cardiovascular, cerebrovascular, and peripheral vascular disease. | 4 | Hermans MP (2023) | The antihyperlipidemic effect of a combined supplement of standardized dry extracts of amla (<i>Emblica officinalis</i>), walnut (<i>Juglans regia</i>), olive (<i>Olea europaea</i>) and red yeast rice (<i>Monascus purpureus</i>) powder: Reduction in circulatory low-density lipoprotein-cholesterol (LDL-C) and remnant cholesterol (RC) levels in patients with hypercholesterolemia. |
| Amla Blood Lipids Meta-Analysis | Conventional drugs such as statins are effective in controlling hyperlipidemia; however, they are associated with various side effects, especially myalgia. | 4 | Hermans MP (2023) | The antihyperlipidemic effect of a combined supplement of standardized dry extracts of amla (<i>Emblica officinalis</i>), walnut (<i>Juglans regia</i>), olive (<i>Olea europaea</i>) and red yeast rice (<i>Monascus purpureus</i>) powder: Reduction in circulatory low-density lipoprotein-cholesterol (LDL-C) and remnant cholesterol (RC) levels in patients with hypercholesterolemia. |
| Amla Blood Lipids Meta-Analysis | Substantial preclinical and clinical evidence suggests that extracts of amla, walnut, and olive, and red yeast rice (RYR) powder possess significant antihyperlipidemic effects. | 4 | Hermans MP (2023) | The antihyperlipidemic effect of a combined supplement of standardized dry extracts of amla (<i>Emblica officinalis</i>), walnut (<i>Juglans regia</i>), olive (<i>Olea europaea</i>) and red yeast rice (<i>Monascus purpureus</i>) powder: Reduction in circulatory low-density lipoprotein-cholesterol (LDL-C) and remnant cholesterol (RC) levels in patients with hypercholesterolemia. |
Source documents